Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun-Bi Ni

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Histopathology|January 16, 2016
Pathological criteria and practical issues in papillary lesions of the breast - a reviewYun-Bi Ni, Gary M Tse
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 23, 2014
[Papillary lesions of the breast]Yun-bi Ni, Gary M Tse
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 24, 2011
[Significance of HER2 testing in breast cancer]Yun-bi Ni, Wen-juan Yang, Hong Bu, et al.
Histopathology|November 27, 2014
GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroupsYun Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
The Oncologist|March 26, 2017
Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast CancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Annals of Surgical Oncology|April 19, 2014
A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinomaYun-Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
Histopathology|November 2, 2018
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breastJoshua Li, Wai-Yee Ho, Julia Y S Tsang, et al.
Journal of Clinical Pathology|June 10, 2015
Associations of epithelial c-kit expression in phyllodes tumours of the breastJohn Tawasil, Edna May L Go, Julia Y S Tsang, et al.
Annals of Surgical Oncology|February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast CancerMaribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Oncotarget|December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Histopathology|January 16, 2016
Pathological criteria and practical issues in papillary lesions of the breast - a reviewYun-Bi Ni, Gary M Tse
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 23, 2014
[Papillary lesions of the breast]Yun-bi Ni, Gary M Tse
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 24, 2011
[Significance of HER2 testing in breast cancer]Yun-bi Ni, Wen-juan Yang, Hong Bu, et al.
Histopathology|November 27, 2014
GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroupsYun Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
The Oncologist|March 26, 2017
Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast CancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Annals of Surgical Oncology|April 19, 2014
A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinomaYun-Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
Histopathology|November 2, 2018
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breastJoshua Li, Wai-Yee Ho, Julia Y S Tsang, et al.
Journal of Clinical Pathology|June 10, 2015
Associations of epithelial c-kit expression in phyllodes tumours of the breastJohn Tawasil, Edna May L Go, Julia Y S Tsang, et al.
Annals of Surgical Oncology|February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast CancerMaribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Oncotarget|December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Pageof 5